PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2018Annals of Surgical Treatment and Research14 citationsOpen Access

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival

JRJinsoo RhuJKJong Man KimGCGyu‐Seong Choi

Key Points

Key points are not available for this paper at this time.

Abstract

Continuing five or more locoregional therapies for recurrent HCC after LR is related to poor recurrence-free survival after SLT.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rhu et al. (2018) studied this question.

synapsesocial.com/papers/69dd27c261d4dd8dbb13373chttps://doi.org/10.4174/astr.2018.95.3.152
Ask AI
Helpful
Bookmark
Share
View Full Paper